A person taking notes from their tablet
Markets

Cabot Sees IBD RS Rating Rise To 76

A person taking notes from their tablet
Shutterstock photo

In a welcome move, Cabot ( CBT ) saw its Relative Strength Rating improve from 69 to 76 on Monday.

[ibd-display-video id=2102289 width=50 float=left autostart=true] This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.

Over 100 years of market history reveals that the top-performing stocks tend to have an 80 or higher RS Rating as they begin their largest price moves. See if Cabot can continue to show renewed price strength and hit that benchmark.

Looking For Winning Stocks? Try This Simple Routine

Cabot is trading within a buy range after climbing above a 63.39 buy point in a cup with handle . The proper buying range extends to 5% above the initial entry. Once a stock hits that benchmark, it's best to wait for it to set up another buying opportunity..

Earnings grew 8% last quarter, up from -13% in the prior report. Revenue also increased, from 14% to 17%. Keep an eye out for the company's next round of numbers on or around Feb. 1.

The company holds the No. 18 rank among its peers in the Chemicals-Specialty industry group. Ferro ( FOE ), KMG Chemicals ( KMG ) and Chase ( CCF ) are among the top 5 highly rated stocks within the group.

RELATED:

Stocks With Rising Relative Strength Ratings

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

FOE CCF CBT

Other Topics

Stocks

Latest Markets Videos